These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 31031744)
1. EB1-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity. Asad M; Sabur A; Shadab M; Das S; Kamran M; Didwania N; Ali N Front Immunol; 2019; 10():616. PubMed ID: 31031744 [TBL] [Abstract][Full Text] [Related]
2. Corrigendum: EBI-3 Chain of IL-35 Along With TGF-β Synergistically Regulate Anti-leishmanial Immunity. Asad M; Sabur A; Shadab M; Das S; Kamran M; Didwania N; Ali N Front Immunol; 2019; 10():2409. PubMed ID: 31681298 [TBL] [Abstract][Full Text] [Related]
3. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis. Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949 [TBL] [Abstract][Full Text] [Related]
4. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice. Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653 [TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of host-protective immune response by regulating Foxp3 expression and Treg function in Leishmania-infected BALB/c mice: critical role of IRF1. Chowdhury BP; Das S; Majumder S; Halder K; Ghosh S; Biswas S; Bandyopadhyay S; Majumdar S Pathog Dis; 2015 Nov; 73(8):ftv063. PubMed ID: 26297915 [TBL] [Abstract][Full Text] [Related]
6. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge. Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980 [TBL] [Abstract][Full Text] [Related]
7. Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis. Sabur A; Bhowmick S; Chhajer R; Ejazi SA; Didwania N; Asad M; Bhattacharyya A; Sinha U; Ali N Front Immunol; 2018; 9():18. PubMed ID: 29441060 [TBL] [Abstract][Full Text] [Related]
8. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. Saha S; Mondal S; Ravindran R; Bhowmick S; Modak D; Mallick S; Rahman M; Kar S; Goswami R; Guha SK; Pramanik N; Saha B; Ali N J Immunol; 2007 Oct; 179(8):5592-603. PubMed ID: 17911647 [TBL] [Abstract][Full Text] [Related]
9. CD4+ CD25+ transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response. Mason CM; Porretta E; Zhang P; Nelson S Clin Exp Immunol; 2007 Jun; 148(3):537-45. PubMed ID: 17362490 [TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta in tegumentary leishmaniasis. Barral-Netto M; Barral A Braz J Med Biol Res; 1994 Jan; 27(1):1-9. PubMed ID: 8173524 [TBL] [Abstract][Full Text] [Related]
11. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice. Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365 [TBL] [Abstract][Full Text] [Related]
12. Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response. Wadhone P; Maiti M; Agarwal R; Kamat V; Martin S; Saha B J Immunol; 2009 Jun; 182(11):7146-54. PubMed ID: 19454711 [TBL] [Abstract][Full Text] [Related]
13. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response. Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865 [TBL] [Abstract][Full Text] [Related]
14. Differential Induction of SOCS Isoforms by Chandrakar P; Parmar N; Descoteaux A; Kar S J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519 [TBL] [Abstract][Full Text] [Related]
15. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice. Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275 [TBL] [Abstract][Full Text] [Related]
16. Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovani. Bhattacharya P; Ghosh S; Ejazi SA; Rahaman M; Pandey K; Ravi Das VN; Das P; Goswami RP; Saha B; Ali N PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004422. PubMed ID: 26829554 [TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani: dynamics of L. donovani evasion of innate immune cell attack due to malnutrition in visceral leishmaniasis. Kumar V; Bimal S; Singh SK; Chaudhary R; Das S; Lal C; Pandey K; Das VR; Das P Nutrition; 2014 Apr; 30(4):449-58. PubMed ID: 24607302 [TBL] [Abstract][Full Text] [Related]
18. Immunity and immunosuppression in experimental visceral leishmaniasis. Goto H; Lindoso JA Braz J Med Biol Res; 2004 Apr; 37(4):615-23. PubMed ID: 15064826 [TBL] [Abstract][Full Text] [Related]
20. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route. Ravindran R; Maji M; Ali N Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]